Share on StockTwits

Investment analysts at Jefferies Group assumed coverage on shares of Auris Medical Holding AG (NASDAQ:EARS) in a note issued to investors on Tuesday, reports. The firm set a “buy” rating and a $12.00 price target on the stock. Jefferies Group’s target price points to a potential upside of 95.12% from the stock’s previous close.

Shares of Auris Medical Holding AG (NASDAQ:EARS) traded down 3.74% during mid-day trading on Tuesday, hitting $5.9199. The stock had a trading volume of 113,849 shares. Auris Medical Holding AG has a 1-year low of $6.00 and a 1-year high of $6.80. The stock has a 50-day moving average of $6.28 and a 200-day moving average of $6.28. The company’s market cap is $167.2 million.

The Fly On The Wall

Receive News & Ratings for Auris Medical Holding AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auris Medical Holding AG and related companies with Analyst Ratings Network's FREE daily email newsletter.